IN8bio Inc reports results for the quarter ended June 30 - Earnings Summary

• IN8bio Inc INAB.OQ reported a quarterly adjusted loss of $1.24​​ per share for the quarter ended June 30, higher than the same quarter last year, when the company reported EPS of $-5.70. The mean expectation of three analysts for the quarter was for a loss of $1.80 per share. Wall Street expected results to range from $-2.10 to $-1.50 per share.

• Reported revenue was zero​; analysts expected zero.

• IN8bio Inc's reported EPS for the quarter was a loss of $1.24​.

• The company reported a quarterly loss of $5.09 million.

• IN8bio Inc shares had risen by 0.5% this quarter and lost 72.8% so far this year.

FORECAST CHANGES

• The mean earnings estimate of analysts was unchanged in the last three months.​

• In the last 30 days, there have been no earnings estimate revisions by analysts covering the company.

RECOMMENDATIONS

• The current average analyst rating on the shares is "buy" and the breakdown of recommendations is 4 "strong buy" or "buy," no "hold" and no "sell" or "strong sell."

• Wall Street's median 12-month price target for IN8bio Inc is $120.00, about 98.2% above its last closing price of $2.15

This summary was machine generated from LSEG data August 8 at 03:17 a.m. UTC. ​All figures in US dollars unless otherwise stated. (For questions concerning the data in this report, contact Estimates.Support@lseg.com. For any other questions or feedback, contact RefinitivNewsSupport@thomsonreuters.com)